The company generated $103.4 million in revenue and net income of $4.04 million for the first half of 2019.IPO prospectusFor the first half of 2019, Progyny generated $103.4 million in revenue and net income of $4.04 million. That's up from $48.4 million in revenue and $3.3 million in net income in the first six months of 2018.
In the filing, the company says its range of benefits have led to above-average fertility outcomes among members, with in-network IVF pregnancy rates of 60.7%, compared to 52.5% across all IVF clinics. The stock will trade under the symbol "PGNY" on the Nasdaq. The lead underwriters are J.P. Morgan, Goldman Sachs and Bank of America Merrill Lynch.Progyny sells health and technology services to large employers, counting
United States United States Latest News, United States United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: CNBC - 🏆 12. / 72 Read more »
Source: BusinessInsider - 🏆 729. / 51 Read more »